Albemarle Corporation

Equities

ALB

US0126531013

Specialty Chemicals

Market Closed - Nyse 04:00:01 2023-12-08 pm EST Intraday chart for Albemarle Corporation 5-day change 1st Jan Change
127.99 USD +2.11% +1.45% -40.98%
This article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
US IRA is 'cream on top' as Arcadium eyes lithium growth RE
UBS Cuts Albemarle Price Target to $130 From $140, Maintains Neutral Rating MT
Anything is possible
Piper Sandler Downgrades Albemarle to Underweight From Neutral, Cuts Price Target to $128 From $140 MT
Analyst recommendations: Broadcom, Deere & Co, Rio Tinto, Lululemon, Nike...
Will Powell deliver an early Christmas present?
ANALYST RECOMMENDATIONS : Abbvie, Boeing, IBM, Lululemon Athletica, Meta Platforms...
Australia's $2.5 trln pension funds set to flex muscles in corporate dealmaking RE
Chile mining body says new lithium projects needed beyond SQM, Albemarle RE
Top Midday Decliners MT
US Equity Indexes Mixed as Stronger Black Friday Sales 'Defy Expectations of Material Slowdown' MT
US Equity Indexes Mixed in Midday Trading MT
Berenberg Bank Adjusts Albemarle Price Target to $135 From $235, Maintains Hold Rating MT
ANALYST RECOMMENDATIONS : Burberry, Albemarle, Linde...
NZ's EBOS not to proceed with $2.44 billion Greencross acquisition RE
Argentina Lithium & Energy Corp. Up 16% After Announcing Accelerated Exploration Plan MT
Albemarle Promotes Cynthia Lima to Chief External Affairs and Communications Officer MT
Albemarle Corporation Announces the Promotion of Cynthia Lima as Senior Vice President, Chief External Affairs and Communications Officer CI
As Aussie magnates gatecrash lithium deals, bankers get creative RE
The ideal scenario is becoming reality
ANALYST RECOMMENDATIONS : Amazon, Best Buy, Diageo, The Mosaic Co, Unilever...
Livent starts Australian campaign for $10.6 billion Arcadium Lithium merger RE
Livent starts Australian campaign for $10.6 bln Arcadium Lithium merger RE
BMO Capital Adjusts Albemarle's Price Target to $180 From $265, Keeps Outperform Rating MT
All good things must come to an end
Chart Albemarle Corporation
More charts
Albemarle Corporation is one of the world's leading manufacturers of specialty chemicals. The group's products are aimed primarily at the petroleum refining, energy storage, consumer electronics, construction, crop protection, automotive, food safety and pharmaceuticals industries. Net sales break down by family of products as follows: - lithium and polymer solutions (68.4%); - bromine (19.3%); - catalysts (12.3%). Exports account for 87.9% of net sales.
Calendar
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
127.99USD
Average target price
188.34USD
Spread / Average Target
+47.15%
Consensus
1st Jan change Capi.
-40.98% 15 020 M $
+31.99% 54 781 M $
+10.83% 44 740 M $
+4.55% 17 377 M $
+3.64% 15 832 M $
+32.03% 9 877 M $
-2.51% 8 760 M $
-27.82% 8 278 M $
-40.50% 8 144 M $
-29.78% 6 229 M $
Other Specialty Chemicals
  1. Stock
  2. Equities
  3. Stock Albemarle Corporation - Nyse
  4. News Albemarle Corporation
  5. Mizuho Adjusts Albemarle's Price Target to $227 From $225, Keeps Neutral Rating
As early as today, start finding the best investment opportunities!
Optimize my profits
fermer